Phytochemical Characterisation and Safety Evaluation of Rosmarinus officinalis Extract for Pharmaceutical Applications

Authors

  • Doyle A Department of Pharmacognosy, University College Dublin, Dublin, Ireland Author
  • Blanchard A Department of Toxicology, University of Lyon, Lyon, France Author
  • Gomez C Department of Pharmaceutics, University of Valencia, Valencia, Spain Author

DOI:

https://doi.org/10.5281/zenodo.22664644

Keywords:

Rosmarinus officinalis, rosmarinic acid, carnosic acid, genotoxicity, acute oral toxicity

Abstract

Background: Rosmarinus officinalis (rosemary) extract is one of the few whole-plant preparations to hold formal regulatory status
as a food antioxidant (EU E392), yet the extract's compositional variability across extraction methods means that safety data
cannot be assumed to transfer freely from one preparation to another.
Objective: To generate a linked phytochemical and nonclinical safety dataset for a single, well-defined ethanolic rosemary extract
batch intended for pharmaceutical and nutraceutical development.
Methods: The extract was characterised by HPLC-DAD for rosmarinic acid, carnosic acid and carnosol content, and by GC-MS for its
volatile constituent profile. The same batch was evaluated in an OECD 423 acute oral toxicity limit test in rats, an MTT-based
cytotoxicity screen across HepG2, Caco-2 and MRC-5 cell lines, and a genotoxicity battery comprising the bacterial reverse mutation
(Ames, OECD 471), in vitro mammalian cell micronucleus (OECD 487), and alkaline comet assays.
Results: The extract contained 6.82% rosmarinic acid, 4.15% carnosic acid and 1.38% carnosol (w/w), with 1,8-cineole, camphor
and α-pinene as the dominant volatiles. No mortality or clinically significant findings occurred at the 2000 mg/kg limit dose
(NOAEL = 2000 mg/kg). Cytotoxicity IC50 values ranged from 164 to 412 μg/mL depending on cell line and exposure time, and all
three genotoxicity assays returned negative results.
Conclusion: This batch-specific dataset supports a favourable safety margin for the characterised extract at pharmaceutically
relevant concentrations and illustrates how tying toxicological findings to a defined phytochemical specification strengthens the
safety case for botanical extract-based pharmaceutical and nutraceutical products.

References

EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (2008) Use of rosemary extracts as a food additive - Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food. EFSA Journal, 6(6):721, DOI:10.2903/j.efsa.2008.721.

Zhang Y, Smuts JP, Dodbiba E, Rangarajan R, Lang JC, Armstrong DW (2012) Degradation Study of Carnosic Acid, Carnosol, Rosmarinic Acid, and Rosemary Extract (Rosmarinus officinalis L.) Assessed Using HPLC. Journal of Agricultural and Food Chemistry, 60(36):9305-9314, DOI:10.1021/jf302179c.

Jordán MJ, Lax V, Rota MC, Lorán S, Sotomayor JA (2012) Relevance of Carnosic Acid, Carnosol, and Rosmarinic Acid Concentrations in the in Vitro Antioxidant and Antimicrobial Activities of Rosmarinus officinalis (L.) Methanolic Extracts. Journal of Agricultural and Food Chemistry, 60(38):9603-9608, DOI:10.1021/jf302881t.

Bansal M, Bhadouria U, Garg S, Sood T, Sharma T (2025) Carnosic Acid: Perspectives on Contemporary Applications, Molecular Mechanisms, and Therapeutic Potential. Revista Brasileira de Farmacognosia, 35(2):333-344, DOI:10.1007/s43450-025-00630-2.

El Kantar S, Yassin A, Nehmeh B, Labaki L, Mitri S, Naser Aldine F, Hirko A, Caballero S, Monck E, Garcia-Maruniak A, Akoury E (2022) Deciphering the therapeutical potentials of rosmarinic acid. Scientific Reports, 12(1):15489, DOI:10.1038/s41598-022-19735-y.

Luo C, Zou L, Sun H, Peng J, Gao C, Bao L, Ji R, Jin Y, Sun S (2020) A Review of the Anti-Inflammatory Effects of Rosmarinic Acid on Inflammatory Diseases. Frontiers in Pharmacology, 11:153, DOI:10.3389/fphar.2020.00153.

Rocha J, Eduardo-Figueira M, Barateiro A, Fernandes A, Brites D, Bronze R, Duarte CMM, Serra AT, Pinto R, Freitas M, Fernandes E, Silva-Lima B, Mota-Filipe H, Sepodes B (2015) Anti-Inflammatory Effect of Rosmarinic Acid and an Extract of Rosmarinus officinalis in Rat Models of Local and Systemic Inflammation. Basic & Clinical Pharmacology & Toxicology, 116(5):398-413, DOI:10.1111/bcpt.12335.

Moore J, Yousef M, Tsiani E (2016) Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols. Nutrients, 8(11):731, DOI:10.3390/nu8110731.

Satyal P, Jones T, Lopez E, McFeeters R, Ali N, Mansi I, Al-kaf A, Setzer W (2017) Chemotypic Characterization and Biological Activity of Rosmarinus officinalis. Foods, 6(3):20, DOI:10.3390/foods6030020.

EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) (2018) Refined exposure assessment of extracts of rosemary (E 392) from its use as food additive. EFSA Journal, 16(8):e05373, DOI:10.2903/j.efsa.2018.5373.

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) (2022) Safety and efficacy of two solvent extracts of rosemary (Rosmarinus officinalis L.) when used as feed additive for cats and dogs (Kemin Nutrisurance Europe SRL). EFSA Journal, 20(1):e06978, DOI:10.2903/j.efsa.2022.6978.

Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B (2018) Safety Assessment of Rosmarinus officinalis (Rosemary)-Derived Ingredients as Used in Cosmetics. International Journal of Toxicology, 37(3 suppl):12S-50S, DOI:10.1177/1091581818800020.

Anadón A, Martínez-Larrañaga MR, Martínez MA, Ares I, García-Risco MR, Señoráns FJ, Reglero G (2008) Acute Oral Safety Study of Rosemary Extracts in Rats. Journal of Food Protection, 71(4):790-795, DOI:10.4315/0362-028X-71.4.790.

Phipps KR, Danielewska-Nikiel B, Mushonganono J, Baldwin N (2021) Reproductive and developmental toxicity screening study of an acetone extract of rosemary. Regulatory Toxicology and Pharmacology, 120:104840, DOI:10.1016/j.yrtph.2020.104840.

Phipps KR, Lozon D, Baldwin N (2021) Genotoxicity and subchronic toxicity studies of supercritical carbon dioxide and acetone extracts of rosemary. Regulatory Toxicology and Pharmacology, 119:104826, DOI:10.1016/j.yrtph.2020.104826.

Ghasemzadeh Rahbardar M, Hosseinzadeh H (2024) Toxicity and safety of rosemary (Rosmarinus officinalis): a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(1):9-23, DOI:10.1007/s00210-024-03336-9.

Hidalgo PJ, Ubera JL, Tena MT, Valcárcel M (1998) Determination of the Carnosic Acid Content in Wild and Cultivated Rosmarinus officinalis. Journal of Agricultural and Food Chemistry, 46(7):2624-2627, DOI:10.1021/jf970974j.

OECD (2002) Test No. 423: Acute Oral Toxicity - Acute Toxic Class Method. OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, DOI:10.1787/9789264071001-en.

Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65(1-2):55-63, DOI:10.1016/0022-1759(83)90303-4.

OECD (2020) Test No. 471: Bacterial Reverse Mutation Test. OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, DOI:10.1787/9789264071247-en.

OECD (2023) Test No. 487: In Vitro Mammalian Cell Micronucleus Test. OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, DOI:10.1787/9789264264861-en.

Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environmental and Molecular Mutagenesis, 35(3):206-221, DOI:10.1002/(SICI)1098-2280(20 00)35:3<206::AID-EM8>3.0.CO;2-J.

Downloads

Published

2026-06-27